|Drug name||N-(4-Hydroxyphenyl)All-Trans Retinamide|
|Description||A synthetic retinoid that is used orally as a chemopreventive against prostate cancer and in women at risk of developing contralateral breast cancer. It is also effective as an antineoplastic agent. [PubChem]|
|DrugBank||Primary Accession Number: DB03922|
|Type||Experimental, Small Molecule|
|Mechanism of Action||Not available|
You need to load/activate the cURL extension (http://www.php.net/cURL).
|Protein Binding||Not available|